Your browser doesn't support javascript.
loading
Research progress on the preparation and application of flavonoid nanocrystals. / 黄酮类化合物纳米晶体的制备及应用研究进展.
Tian, Yiting; Shi, Zhiqun; Ma, Huiping.
Afiliação
  • Tian Y; Department of Pharmacy, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Key Laboratory of the Plateau Medicine, Lanzhou 730050, China. tianyiting2019@163.com.
  • Shi Z; College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou 730000, China. tianyiting2019@163.com.
  • Ma H; Department of Pharmacy, the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Key Laboratory of the Plateau Medicine, Lanzhou 730050, China.
Zhejiang Da Xue Xue Bao Yi Xue Ban ; 52(3): 338-348, 2023 Jun 25.
Article em En, Zh | MEDLINE | ID: mdl-37476945
Flavonoids have been reported to possess significant pharmacological activities,such as antioxidant, anti-inflammatory and anticancer effects. However, the low solubility and low bioavailability limits their clinical application. Nanocrystal technology can solve the delivery problems of flavonoids by reducing particle size, increasing the solubility of insoluble drugs and improving their bioavailability. This article summaries nanosuspension preparation methods and the stabilizers for flavonoid nanocrystals, and reviews the drug delivery routes including oral, Injection and transdermal of flavonoid nanocrystals, to provide information for further research on nanocrystal delivery system of flavonoids.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Flavonoides / Nanopartículas Idioma: En / Zh Revista: Zhejiang Da Xue Xue Bao Yi Xue Ban Assunto da revista: MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Flavonoides / Nanopartículas Idioma: En / Zh Revista: Zhejiang Da Xue Xue Bao Yi Xue Ban Assunto da revista: MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China